SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5mL Glass/Multiple Do...

FDA Recall #D-0778-2017 — Class II — April 18, 2017

Recall #D-0778-2017 Date: April 18, 2017 Classification: Class II Status: Terminated

Product Description

SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5mL Glass/Multiple Dose via, Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling Firm

Key Pharmacy and Compounding Center — Federal Way, WA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2 vials

Distribution

Distributed nationwide in U.S.A., Australia and Canada.

Code Information

Lot # t01-26-2017@94, Exp 4/27/2017

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated